Pulmatrix, Inc. — Director's Dealing 2017

Mar 22, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulmatrix, Inc. (PULM)
CIK: 0001574235
Period of Report: 2017-03-20

Reporting Person: Hava David L. (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-22	Common Stock	M	2263	$2.21	Acquired	2263	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-03-20	Stock Option (Right to Buy)	$2.78	A	75100	Acquired	2027-03-20	Common Stock (75100)	Direct
2017-03-22	Stock Option (Right to Buy)	$2.21	M	2263	Disposed	2020-02-10	Common Stock (2263)	Direct

Footnotes

F1: The option vests as to 25% on March 20, 2018 and the remaining 75% vests in thirty-six (36) equal monthly installments with 2.083% vesting for each of the next thirty-six (36) months that follow March 20, 2018, subject to the terms and conditions of the Pulmatrix, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan.

F2: The option, representing the right to purchase a total of 3,555 shares of common stock, was fully vested and exercisable as of February 10, 2014.

F3: On March 22, 2017, the Reporting Person acquired 2,263 shares of common stock upon a partial exercise of this option. Following the exercise, the Reporting Person may acquire an additional 1,292 shares of common stock pursuant to this option.